logo
In search of the eighth factor
Pros and cons of thrombophilia testing
Pros and cons of thrombophilia testing
LMWH contra LMWH
Maternal anticoagulant prophylaxis for prevention of pregnancy loss in women with thrombophilia
Atherothrombosis and the pill
Thalidomide and thrombosis in multiple myeloma
The concept of recombinant factor VIIa megadose for treating bleeding episodes in high‐titer inhibitor patients with hemophilia
Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty
Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia
The RATIO study
Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment
A new approach to treatment of bleeding episodes in young hemophilia patients
Molecular mechanisms of mild and moderate hemophilia A
The participation of leukocytes in coagulant reactions
Biphasic pro‐thrombotic and inflammatory responses after coronary artery bypass surgery
Platelet functional defects in women with unexplained menorrhagia
Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP)
Role of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with acute pulmonary embolism
Effect of graduated elastic compression stockings on leg symptoms and signs during exercise in patients with deep venous thrombosis
Use of elastic compression stockings after deep venous thrombosis
Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis
Blood coagulation in anhepatic pigs
Inter‐relation of coagulation factors and D‐dimer levels in healthy individuals
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies
The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
Inaccuracy of international normalized ratio (INR) measurements and suggestions for improved WHO guidelines for calibration of reference preparations – a statistical study
Occurrence of O‐linked Xyl‐GlcNAc and Xyl‐Glc disaccharides in trocarin, a factor Xa homolog from snake venom
Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation
von Willebrand factor stimulates thrombin‐induced exposure of procoagulant phospholipids on the surface of fibrin‐adherent platelets
Pro‐ and antioxidant activities of docosahexaenoic acid on human blood platelets
Analysis of platelet membrane glycoprotein polymorphisms in Glanzmann thrombasthenia showed the French gypsy mutation in the αIIb gene to be strongly linked to the HPA‐1b polymorphism in β3
Role of in vitro cholesterol depletion in mediating human platelet aggregation
The benefit‐to‐risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model
Choice of replacement therapy for hemophilia
Choice of replacement therapy for hemophilia
Choice of low molecular weight heparins
Choice of low molecular weight heparins
Choice of low molecular weight heparins
Choice of low molecular weight heparins
Etonogestrel implant use is not related to hypercoagulable changes in anticoagulant system
Factor X Leicester
Prostacyclin is a platelet activator when protein kinase A is inhibited
Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia
Talking about...
……Industry
………Authority
……. Patients
……. People
Platelets in Thrombotic and Non‐Thrombotic Disorders
Announcements
Peter C. Harpel
Analysis of the consequences of premature termination codons within factor VIII coding sequences